首页> 外文期刊>The Open Genomics Journal >Interferon α-Inducible Protein 27 Computational Network Construction and Comparison between the Frontal Cortex of HIV Encephalitis (HIVE) and HIVE-Control Patients?
【24h】

Interferon α-Inducible Protein 27 Computational Network Construction and Comparison between the Frontal Cortex of HIV Encephalitis (HIVE) and HIVE-Control Patients?

机译:干扰素α诱导蛋白27计算网络的构建以及HIV脑炎(HIVE)与HIVE对照患者的额叶皮层之间的比较?

获取原文
           

摘要

Interferon -inducible protein 27 (IFI27) computational network construction and analysis of frontal cortex of HIV encephalitis (HIVE) is very useful to identify novel markers and potential targets for prognosis and therapy. Based on integrated gene regulatory network infer (GRNInfer) method by linear programming and a decomposition procedure with analysis of the significant function cluster using Kappa statistics and fuzzy heuristic clustering from DAVID, we identified and constructed significant molecular IFI27 networks from 12 frontal cortex of HIVE-control patients and 16 HIVE in the same GEO Dataset GDS1726. Our integrative results reflected an IFI27 membrane module only in the upstream of the frontal cortex of HIVE-control patients (BTN3A2, RASGRP3, ROR1 inhibition), and the frontal cortex of HIVE (DGKG, LY96 activation; RASGRP3 inhibition); IFI27 organelle only in the upstream of HIVE-control patients (CREB5, OAS1, PDCD4 activation), and HIVE (PDCD4 activation; ZC3HAV1, ZNF652 inhibition); IFI27 sequence variant only in the upstream of HIVE-control patients (ISG15_2, OAS1, TNFRSF11B activation; BTN3A2, LCAT, ROR1 inhibition), and HIVE (CFB, DGKG, LCAT, LY96 activation; ISG15_2, TNFRSF11B, ZC3HAV1 inhibition).
机译:干扰素诱导蛋白27(IFI27)计算网络的构建以及HIV脑炎(HIVE)额叶皮层的分析对于确定新的标记物和预测和治疗的潜在靶点非常有用。基于线性规划的综合基因调控网络推论(GRNInfer)方法以及基于Kappa统计数据和DAVID的模糊启发式聚类分析的重要功能簇的分解程序,我们从HIVE-的12个额叶皮层中识别并构建了重要的分子IFI27网络。在相同的GEO数据集GDS1726中控制患者和16位HIVE。我们的综合结果反映了仅在HIVE对照患者的额皮质上游(BTN3A2,RASGRP3,ROR1抑制)和HIVE额皮质的上游(DGKG,LY96激活; RASGRP3抑制)具有IFI27膜组件。 IFI27细胞器仅在HIVE对照患者(CREB5,OAS1,PDCD4激活)和HIVE(PDCD4激活; ZC3HAV1,ZNF652抑制)的上游; IFI27序列变异仅在HIVE对照患者的上游(ISG15_2,OAS1,TNFRSF11B激活; BTN3A2,LCAT,ROR1抑制)和HIVE(CFB,DGKG,LCAT,LY96激活; ISG15_2,TNFRSF11B,ZC3HAV1抑制)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号